药品名称:Revolade 25 mg 14 tab药品简介:治疗适应症Revolade适用于自诊断后持续6个月或更长时间且对其他治疗(例如皮质类固醇,免疫球蛋白)无效的1岁及以上的原发性免疫性血小板减少症(ITP)的患者的治疗。在患有慢性丙型肝炎病毒(HCV)感染的成年患者中,应发生革命性反应,以治疗血小板减少症,其中血小板减少症的程度是阻止其开始或限制维持最佳干扰素疗法的主要因素。在患有获得性严重再生障碍性贫血(SAA)的成年患者中出现了恶变,这些患者要么对先前的免疫抑制治疗无效,要么经过严格的预处理,不适合进行造血干细胞移植药品通用名:Eltrombopag厂商:NOVARTIS剂型:片...
药品名称:Revolade 25 mg 14 tab药品简介:治疗适应症Revolade适用于自诊断后持续6个月或更长时间且对其他治疗(例如皮质类固醇,免疫球蛋白)无效的1岁及以上的原发性免疫性血小板减少症(ITP)的患者的治疗。在患有慢性丙型肝炎病毒(HCV)感染的成年患者中,应发生革命性反应,以治疗血小板减少症,其中血小板减少症的程度是阻止其开始或限制维持最佳干扰素疗法的主要因素。在患有获得性严重再生障碍性贫血(SAA)的成年患者中出现了恶变,这些患者要么对先前的免疫抑制治疗无效,要么经过严格的预处理,不适合进行造血干细胞移植药品通用名:Eltrombopag厂商:NOVARTIS剂型:片...
药品名:Betnesol活性物质:neomycin sulfate/betamethasone sodium phosphate剂型:Solution药品授权编号:PL 36301/0004上市时间:1992-09-03持证商:RPH Pharmaceuticals AB持证商地址:Lagervägen 7,136 50 Haninge,Sweden生产商:Excelvision生产商地址:27, rue de la Lombardière, ZI La Lombardière, 07100 Annonay药品说明书:PDF(中文) PDF(英文)包装说明...
药品名:Zevtera剂量:500mg剂型:solution for infusion适应症:- Hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP)- Community-acquired pneumonia (CAP)药品授权编号:PL 48998/0001上市时间:2013-11-20持证商:Correvio持证商地址:15 Rue du Bicentenaire 92800 Puteaux France持证商电话:+ 44 (0)203 002 8114持...
药品名:DAXAS活性物质:roflumilast剂量:250 micrograms剂型:Tables适应症:Daxas is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbat...
药品名:Covonia Sore Throat活性物质:chlorhexidine gluconate/lidocaine hydrochloride剂型:Oromucosal spray适应症:Covonia Sore Throat Spray is indicated for the symptomatic relief of painful, irritated sore throats.Covonia喉咙痛喷雾适用于疼痛,烦躁喉咙痛的症状缓解。It is a sugar free preparation and can be used by diabetics.这是一种无糖制剂,可供糖...
药品名:Propylthiouracil活性物质:Propylthiouracil剂量:50mg剂型:Tables适应症:1. Management of hyperthyroidism, including the treatment of Graves' disease and thyrotoxicosis.1.甲亢的治疗,包括治疗格雷夫斯病和甲状腺毒症。2. Amelioration of hyperthyroidism in preparation for surgical treatment.2.改善甲状腺功能亢进以备手术治疗。3. An adjunct to radioactive...
药品名:COMBISAL 活性物质:Salmeterol (as xinafoate)/Fluticasone Propionate 剂量:25 microgram/250 microgram 剂型:suspension药品编号: PL 36532/0001上市时间:2017-11-10持证商:Genetic S.p.A. 持证商地址:Via G. Della Monica 26, 84083 Castel San Giorgio (SA), Italy 生产商:Geneti...
药品名:COMBISAL 活性物质:Salmeterol (as xinafoate)/Fluticasone Propionate 剂量:25 microgram/125 microgram 剂型:suspension 药品编号:PL 36532/0002上市时间:2017-10-11持证商:Genetic S.p.A.持证商地址:Via G. Della Monica 26, 84083 Castel San Giorgio (SA), Italy 生产商:Genetic S.p.A. 生产商地址: Contrada Canfor...
药品名:COMBISAL活性物质:Salmeterol (as xinafoate)/Fluticasone Propionate 剂量:25 microgram/50 microgram剂型:suspension药品编号:PL 36532/0001上市时间:2017-10-11持证商:Genetic S.p.A.持证商地址:Via G. Della Monica 26, 84083 Castel San Giorgio (SA), Italy生产商:Genetic S.p.A.生产商地址: Contrada Canfora 84084 Fisciano, (SA), Italy分销商:Asp...
商标名:Brabio活性物质:glatiramer acetate剂量:40 mg/ml剂型:solution for injection持证商:Mylan持证商地址: Potters Bar Hertfordshire EN6 1TL United Kingdom生产商1:Synthon Hispania SL生产商1地址:Castelló 1, Poligono Las Salinas, 08830 Sant Boi de Llobregat, Spain生产商2:Synthon BV商产商2地址:Microweg 22, 6545 CM Nijme...